Sunshine Biopharma, Lonza manufacture anti-cancer drug

Sunshine Biopharma, Lonza to manufacture anti-cancer drug

12:24 PM, 20th November 2014
Sunshine Biopharma, Lonza to manufacture anti-cancer drug

MONTREAL, CANADA: Sunshine Biopharma Inc, a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, announced an agreement with Lonza, a leading development and manufacturing company, for the manufacture of its anti-cancer drug, Adva-27a.

Lonza’s expertise and experience in small molecule development and manufacturing of active pharmaceutical ingredients, was an ideal fit for Sunshine’s Adva-27a. Lonza’s manufacturing capacity ranges from gram quantities for process validation to kilogram amounts for clinical trials and tonne quantities for commercialization. Manufacturing will begin at Lonza’s Nansha, China facility with the remaining key steps to be conducted in Lonza’s high containment cytotoxic facility in Visp, Switzerland.

“We are delighted to have a global leader like Lonza as our manufacturing partner. We have made significant recent strides in terms of research results showing the effectiveness of our lead compound against cancer cells as well as in our manufacturing and recent fund raising efforts,” said Dr Steve N Slilaty, President and CEO, Sunshine Biopharma.


© Worldofchemicals News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

“Fool’s gold” can efficiently convert sunlight into electricity

MADISON, US: As the installation of photovoltaic solar cells continues to accelerate, scientists are looking for inexpensive materials beyond the trad ...

Read more
Kemira opens new production plant in Nanjing, China

NANJING, CHINA: Kemira celebrated the completion of the company’s new production base in Nanjing, China. Kemira’s already completed and fu ...

Read more
Orica to sell chemicals business to Blackstone for $652 million

VICTORIA, AUSTRALIA: Orica Limited has entered into an agreement to sell its chemicals business to funds advised by Blackstone for A$750 million ($652 ...

Read more
ADM completes acquisition of Specialty Commodities

CHICAGO, US: Archer Daniels Midland Company (ADM) had completed its acquisition of Specialty Commodities Inc, a leading originator, processor and dist ...

Read more
New computer model could identify unknown chemical mechanisms

CALIFORNIA, US: A new computer model could identify unknown chemical mechanisms that could improve energy production and storage, or the development o ...

Read more
New novel cathode to make cheap, flexible dye-sensitized solar cells

HOUSTON, US: Rice University scientists have invented a novel cathode that may make cheap, flexible dye-sensitized solar cells practical. The Rice lab ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X